Vancouver, British Columbia–(Newsfile Corp. – January 18, 2022) – Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) (“ Entheon” or the “Company“)announced that it has filed a preliminary short form base shelf prospectus dated January 14, 2022 (the “Preliminary Prospectus“) with the securities commissions in each of the provinces and territories of Canada.
